Glaucoma (Newton Laboratories, Inc.)
Welcome to the PulseAid listing for the Glaucoma drug offered from Newton Laboratories, Inc.. This Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Newton Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Aconitum nap., Aur. met., Belladonna, Causticum, Cinchona, Colchicum, Euphrasia, Gelsemium, Nux vom., Osmium metallicum, Phosphorus, Physostigma, Rhus toxicodendron, Spigelia anth. |
| SUBSTANCE NAME: | ACONITUM NAPELLUS; GOLD; ATROPA BELLADONNA; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; STRYCHNOS NUX-VOMICA SEED; OSMIUM; PHOSPHORU |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Glaucoma HUMAN PRESCRIPTION DRUG Details:
| Item Description | Glaucoma from Newton Laboratories, Inc. |
| LABELER NAME: | Newton Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15([hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g) |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55714-4581_f9b9f588-fd69-3ec2-1fd1-991ce8039491 |
| PRODUCT NDC: | 55714-4581 |
| APPLICATION NUMBER: | |
Other ACONITUM NAPELLUS; GOLD; ATROPA BELLADONNA; CAUSTICUM; CINCHONA OFFICINALIS BARK; COLCHICUM AUTUMNALE BULB; EUPHRASIA STRICTA; GELSEMIUM SEMPERVIRENS ROOT; STRYCHNOS NUX-VOMICA SEED; OSMIUM; PHOSPHORU Pharmaceutical Manufacturers / Labelers:
